- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Epigral Limited — Board Meeting, 10-11-2025: Outcome of Board Meeting
10-11-2025 | 01:26 pm
10-11-2025 | 01:26 pm
Epigral's Board approved consolidated Q2 & H1 financial results ending Sept 30, 2025: PAT for Q2 stood at 51.22 Cr, H1 at 211.91 Cr. Mr. Rakesh Agrawal was appointed CFO. The company also highlighted ongoing investment in a 19.80 MW wind-solar hybrid power plant.
No comments yet. Be the first to comment!